Moderna CEO wants to give FDA ‘flexibility’ for 2nd booster eligibility

When Moderna submitted its FDA request for the emergency use authorization of a second booster shot of its COVID-19 vaccine, the drugmaker included all adults. CEO Stephane Bancel told CNBC this choice was meant to give the agency flexibility in determining who would be eligible to receive the second shot.

Read the full post on Becker's Hospital Review - Healthcare News